These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 2483572

  • 21. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
    Kisicki JC, Fiske K, Lyne A.
    Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
    [Abstract] [Full Text] [Related]

  • 22. Comparison of nitrendipine combined with low-dose hydrochlorothiazide to hydrochlorothiazide alone in mild to moderate essential hypertension.
    Schoenberger JA, Glasser SP, Ram CV, McMahon SG, Vanov SK, Leibowitz DA.
    J Cardiovasc Pharmacol; 1984 Sep; 6 Suppl 7():S1105-8. PubMed ID: 6085376
    [Abstract] [Full Text] [Related]

  • 23. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [Abstract] [Full Text] [Related]

  • 24. Low dosages of felodipine ER once daily as monotherapy in elderly hypertensive patients: effect on ambulatory blood pressure and quality of life.
    van Ree JW, van der Pol GA.
    J Hum Hypertens; 1996 Sep; 10(9):613-8. PubMed ID: 8953207
    [Abstract] [Full Text] [Related]

  • 25. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group.
    Joglekar SJ, Jaguste V, Nanivadekar AS.
    J Assoc Physicians India; 1998 Sep; Suppl 1():41-51. PubMed ID: 11233386
    [Abstract] [Full Text] [Related]

  • 26. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
    McMahon FG, Weinstein SP, Rowe E, Ernst KR, Johnson F, Fujioka K, Sibutramine in Hypertensives Clinical Study Group.
    J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
    [Abstract] [Full Text] [Related]

  • 27. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group.
    Misra KP, Joglekar SJ, Mukherjee S, Nanivadekar AS.
    J Assoc Physicians India; 1998 Jan; Suppl 1():30-40. PubMed ID: 11233385
    [Abstract] [Full Text] [Related]

  • 28. The use of nitrendipine in the treatment of elderly hypertensives.
    Pandita-Gunawardena ND, Macdonald G.
    Eur Heart J; 1987 Nov; 8 Suppl K():57-62. PubMed ID: 3450522
    [Abstract] [Full Text] [Related]

  • 29. Differential time effect profiles of amlodipine, as compared to valsartan, revealed by ambulatory blood pressure monitoring, self blood pressure measurements and dose omission protocol.
    Radauceanu A, Boivin JM, Bernaud C, Fay R, Zannad F, CIC General Practitioners Investigators' Group.
    Fundam Clin Pharmacol; 2004 Aug; 18(4):483-91. PubMed ID: 15312156
    [Abstract] [Full Text] [Related]

  • 30. Clinic blood pressure responses to two amlodipine salt formulations, adipate and besylate, in adult Korean patients with mild to moderate hypertension: a multicenter, randomized, double-blind, parallel-group, 8-week comparison.
    Lee HY, Kang HJ, Koo BK, Oh BH, Heung-Sun K, Kim KS, Seo HS, Ro YM, Kang JH, Woong CJ, Joo SJ, Kim MH, Joon-Han S, Yoon J, Park SH, Jin-Ok J, Ju AK, Chong-Yun R, Yeon KJ, Park KM, Lim DK, Park SY, Amostar Study Investigators.
    Clin Ther; 2005 Jun; 27(6):728-39. PubMed ID: 16117979
    [Abstract] [Full Text] [Related]

  • 31. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, Schneider H, Pospiech R.
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [Abstract] [Full Text] [Related]

  • 32. Efficacy and tolerability of manidipine hydrochloride in the long-term treatment of mild-moderate hypertension. Manidipine Efficacy in Long-Term Treatment Group.
    Fogari R, Zoppi A, Lusardi P, Mugellini A.
    Blood Press Suppl; 1996 Apr; 5():24-8. PubMed ID: 8973789
    [Abstract] [Full Text] [Related]

  • 33. Nitrendipine in older patients with isolated systolic hypertension: second progress report on the SYST-EUR trial.
    Staessen J, Bert P, Bulpitt C, De Cort P, Fagard R, Fletcher A, Kivinen P, Lehtomaki E, Leonetti G, O'Brien E.
    J Hum Hypertens; 1993 Jun; 7(3):265-71. PubMed ID: 8345494
    [Abstract] [Full Text] [Related]

  • 34. Circadian rhythm of blood pressure and calcium entry blockade: a chronobiologic study with nitrendipine in essential hypertension.
    Mele D, Manfredini R, Amadei GA, Sgobino P, Longhini C, Fersini C.
    J Cardiovasc Pharmacol; 1991 Jun; 18 Suppl 1():S51-4. PubMed ID: 1723456
    [Abstract] [Full Text] [Related]

  • 35. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL, Glazer R, Weinberger M, Alvarado R, Huang J, Graff A.
    Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
    [Abstract] [Full Text] [Related]

  • 36. Effect of bisoprolol and acebutolol on resting blood pressure and on exercise blood pressure profile in hypertensive patients: a comparative, single-blind study.
    Bouvier JM, Rabot D, Herrero G.
    J Cardiovasc Pharmacol; 1990 Jan; 16 Suppl 5():S179-83. PubMed ID: 11527124
    [Abstract] [Full Text] [Related]

  • 37. The calcium channel blocker nitrendipine in single- and multiple-agent antihypertensive regimens: preliminary report of a multicenter study.
    Weber MA, Drayer JI.
    J Cardiovasc Pharmacol; 1984 Jan; 6 Suppl 7():S1077-84. PubMed ID: 6085371
    [Abstract] [Full Text] [Related]

  • 38. Medium-term effects of betaxolol monotherapy and combination therapy with nitrendipine on lipoprotein and apolipoprotein metabolism in patients with mild to moderate essential hypertension.
    Saku K, Zhang B, Okamoto T, Takeda Y, Liu K, Jimi S, Arakawa K.
    J Hum Hypertens; 1996 Apr; 10(4):263-8. PubMed ID: 8736459
    [Abstract] [Full Text] [Related]

  • 39. Metabolic effects of nitrendipine.
    Paolisso G, Aceto E, Cennamo G, D'Amore A, Varricchio M.
    Clin Ther; 1991 Apr; 13(6):695-8. PubMed ID: 1790544
    [Abstract] [Full Text] [Related]

  • 40. Antihypertensive efficacy of a slow release nifedipine tablet formulation given once daily in patients with mild to moderate hypertension. A placebo-controlled, double-blind parallel-group trial.
    Harder S, Rietbrock S, Thürmann P.
    Arzneimittelforschung; 1994 Feb; 44(2):133-6. PubMed ID: 8147945
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.